|
"du js"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024-09 |
TCOG T5221 trial: A phase II randomized study of gemcitabine and nab-paclitaxel in combination with S-1/LV (GASL) or oxaliplatin (GAP) as first-line treatment for metastatic pancreatic cancer
|
Su, YY;Bai, LY;Huang, CJ;Chiu, CF;Wang, HT;Du, JS;Wang, HC;Chuang, S;Shih, YH;Lin, HC;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2024-06-21 |
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study
|
Tsai, HJ;Yang, SH;Hsiao, CF;Kao, HF;Su, YY;Shan, YS;Yen, CJ;Du, JS;Hsu, C;Wu, IC;Chen, LT |
| 國家衛生研究院 |
2023-11-22 |
The prognosis performance of a neutrophil- and lymphocyte-associated gene mutation score in a head and neck cancer cohort
|
Yeh, TJ;Wang, HC;Cho, SF;Wu, CC;Hsieh, TY;Huang, CT;Wang, MH;Chuang, TM;Gau, YC;Du, JS;Liu, YC;Hsiao, HH;Pan, MR;Chen, LT;Moi, SH |
| 國家衛生研究院 |
2023-05-01 |
The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy
|
Wang, HC;Moi, SH;Chan, LP;Wu, CC;Du, JS;Liu, PL;Chou, MC;Wu, CW;Huang, CJ;Hsiao, HH;Pan, MR;Chen, LT |
| 國家衛生研究院 |
2023-02-24 |
Deciphering the functions of telomerase reverse transcriptase in head and neck cancer
|
Yeh, TJ;Luo, CW;Du, JS;Huang, CT;Wang, MH;Chuang, TM;Gau, YC;Cho, SF;Liu, YC;Hsiao, HH;Chen, LT;Pan, MR;Wang, HC;Moi, SH |
| 國家衛生研究院 |
2022-09-21 |
Clustering of chromatin remodeling enzymes predicts prognosis and clinical benefit of therapeutic strategy in pancreatic cancer
|
Wang, HC;Shih, HY;Wu, CC;Chen, LT;Luo, CW;Liu, YC;Du, JS;Huang, MC;Su, YY;Chen, HD;Hsiao, HH;Moi, SH;Pan, MR |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
